HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Small Business Matters

HBW Insight’s coverage of news and issues impacting small and mid-sized enterprises.

Haleon's Nick Tate: Tech Partnerships Key To Unlocking Digital Consumer Health Future

“There’s no one company, government, person or technology who is positioned to ‘solve’ the health of the world,” notes Haleon's Nick Tate. Which is why OTC companies are partnering with tech firms large and small to create the next generation of consumer healthcare products and services. In the first part of an exclusive interview on the future of digital consumer health, Tate – who heads up the firm’s incubator business, Haleon NEXT – discusses some of the complications of tech innovation that make such collaboration attractive.

Futura Launches Eroxon Erectile Dysfunction Gel In Europe, US Launch Delayed Until Q2 2023

European consumers can now buy Futura Medical's Eroxon erectile dysfunction gel without a prescription online, and in person via Belgian pharmacies. Further country launches, supported by advertising and promotional campaigns, remain on track during the coming months, Futura says. However, the US launch, expected for Q1 this year, has been delayed while the firm answers questions posed by the FDA.

UK’s Idavøll Viking-Themed Supplement Seeks To Conquer Men’s Sexual Wellness Category

UK start-up Idavøll has created a “sexual performance” supplement containing a mixture of botanicals, minerals and amino acids designed to contribute towards optimal stamina, blood flow, testosterone levels and mental performance. Speaking exclusively to HBW Insight, the firm's CEO Dan Barron reveals plans to take the Viking themed brand to Europe, China and the US. 

UK’s OptiBiotix Offers GoFigure Prebiotic Range To Slim Down Saudi Arabia’s ‘Alarming’ Obesity Rates

Thanks to a deal with local pharmacy chain Nahdi Medical, slimmers in the Kingdom of Saudi Arabia will soon be able to buy GoFigure shakes and bars, which contain OptiBiotix Health's trademarked SlimBiome prebiotic.

GSCF World Congress: Digital, Data & Innovation In Self-Care

The healthcare industry is sick and in desperate need of disruption, stated Consumer Healthcare Products Association president Scott Melville at the beginning of the final session of the 2022 GSCF World Congress. Thought leaders from Google, past and present, Haleon, IQVIA Consumer Health and Convert Group offered their views on where this disruption might come from. 

Londoners Get J&J Brands 'In Minutes' 24/7 Via Zapp Partnership

Johnson & Johnson's OTC brands including Benadryl, Benylin, Calpol, Imodium, Nicorette and Sudafed, as well as its personal care brands such as Aveeno and Neutrogena, are now available for home delivery 24/7 via the Zapp app to consumers in London, UK.

Futura All Set For US FDA De Novo Application For Eroxon OTC ED Treatment

Futura Medical is preparing to seek approval from the FDA to launch OTC in the US its MED3000 erectile dysfunction treatment, marketed in Europe under the Eroxon brand name. After completing all the necessary studies demonstrating that the gel-based, drug-free product works as a self-care treatment for ED, Futura says it is confident that the soon to be submitted de novo medical device application will be successful and pave the way for a Q1 2023 launch.

CEO Don Frey On Helming Independent Beauty Association In ‘Unprecedented’ Climate

Joining IBA from The Honest Company, where he headed up innovation, Frey aims to promote networking and collaboration within the group’s membership in an environment where in-person events – and travel budgets – still have not returned to pre-pandemic levels. Frey spoke with HBW Insight about his career to date and his goals for IBA in the near and longer terms.

Positive Study Results Put Futura’s OTC Erectile Dysfunction Gel On Track For 2023 US Launch

Positive results from a confirmatory Phase III clinical study puts Futura Medical on track to file a dossier for drug-free erectile dysfunction gel MED3000 with the US Food and Drug Administration by the end of September 2022. This is in line with the company's timeline of approval as an OTC de novo medical device in Q1 2023.

Digital Home-Testing Is The Future, Says Bloom Diagnostics Co-Founder Angelica Kohlmann

With its lateral flow at-home tests for ferritin, thyroid function and ovarian reserves, Swiss medtech firm Bloom Diagnostics thinks it has seen the future of consumer healthcare. HBW Insight speaks to co-founder and board chair Angelica Kohlmann about the firm's Bloom Lab technology and forward-looking plans, including a possible US launch. 

Plantwise Launches Supplement Line Focusing On 'Specialized Retailers'

Plantwise launched its CBD supplements in independent pharmacies in May with consultation consumers might not receive at larger chains.

Hot Flash! Menopause May Not Be Sexy, But Investors Are Warming To Digital Health Solutions

Menopause market is a multi-billion opportunity gaining traction with digital health companies offering solutions to help women manage their symptoms and provide treatment and support. Medtech Insight spoke with three female founders and entrepreneurs, as well as a partner at Lux Capital and clinical lead of ORCHA, about this market.